New frontiers of target therapy in oncology: acute promyelocytic leukemia

New frontiers of target therapy in oncology: acute promyelocytic leukemia

Uvođenjem all-trans retinoične kiseline (ATRA) u de novo akutnoj promijelocitnoj leukemiji (APL) napravljena je revolucija u terapiji ove bolesti. Stopa molekularnih kompletnih remisija (CR) udvostručila se u odnosu na konvencionalnu hemioterapiju antraciklinima i kreće se 90-95%. Konsolidaciona ter...

Full description

Bibliographic Details
Main Authors: Petković Ivan, Pejčić Ivica, Vrbić Svetislav
Format: Article
Language:English
Published: Sciendo 2014-03-01
Series:Acta Facultatis Medicae Naissensis
Subjects:
acute promyelocytic leukemia
target therapy
akutna promijelocitna leukemija
ciljana terapija
Online Access:http://www.degruyter.com/view/j/afmnai.2014.31.issue-1/afmnai-2014-0002/afmnai-2014-0002.xml?format=INT

Internet

http://www.degruyter.com/view/j/afmnai.2014.31.issue-1/afmnai-2014-0002/afmnai-2014-0002.xml?format=INT

Similar Items